Icpd

Established in 1991, Albany Molecular Research is a chemistry-based drug discovery, development and manufacturing company focused on applications for new small molecule prescription drugs. The company provides chemistry services for pharmaceutical and biotechnology companies and conducts its own proprietary research and development. Albany Molecular Research is involved in all stages of the drug discovery process from identifying leads for validated targets to lead optimization, scale-up, in vitro metabolism, and synthesis and manufacturing for clinical trials and commercial products. Its research has led to dozens of issued and pending patents, which include patents for the active ingredient in the non-sedating antihistamine Allegra, developed and marketed by Sanofi-Aventis. The company performs contract chemistry services and bioscience technologies at several laboratory research and manufacturing facilities in the United States and internationally. Albany Molecular Research is headquartered in Albany, N.Y.

Glauconix Biosciences, Inc., located in Albany, NY, specializes in advancing medicine through innovative 3D human tissue technology. The company is focused on developing various vascular and fibrotic models, including those for retinal vascular dysfunction, pulmonary arterial hypertension, glaucoma, and pulmonary fibrosis. Dedicated to research and development, Glauconix Biosciences aims to enhance understanding and treatment options for complex medical conditions. Their commitment to scientific advancement is reflected in their growing portfolio of models and resources. Generated from the website

Nanopharmaceuticals LLC is a cutting-edge biotechnology company based in Rensselaer, NY, specializing in the research and development of advanced nanomedicines. With a strong focus on therapeutic innovation, the company is dedicated to revolutionizing the field of medicine through its groundbreaking science and clinical trials. Driven by a commitment to intellectual property and scientific excellence, Nanopharmaceuticals LLC aims to address unmet medical needs and improve patient outcomes. With a robust pipeline of nanopharmaceuticals, the company is poised to make significant contributions to the healthcare industry in the coming years.Generated from the website